Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

NCT04518475 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Thrombocytopenia (ITP)

Interventions

DRUG: eltrombopag combining rituximab
DRUG: eltrombopag

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]